Poloxamer coated fluticasone propionate microparticles for pulmonary delivery; In vivo lung deposition and efficacy studies

Indian Journal of Pharmaceutical Sciences

Volumn 69, Issue 5, 2007, Pages 714-715

  Singh, D ^a   Parmar, J ^a   Hegde, D ^a   Menon, M ^a   Soni, P ^b   Samad, A ^c   Gaikwad, R ^c  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b Board of Radiation and Isotope Technology and Medical Cyclotron Facility   (India)

^c BOMBAY VETERINARY COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; MICROSPHERE; OVALBUMIN; POLOXAMER; TECHNETIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ASTHMA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; EOSINOPHIL; GAMMA SCINTIGRAPHY; IN VIVO STUDY; ISOTOPE LABELING; LUNG SCINTISCANNING; LYMPHOCYTE; MACROPHAGE; NEUTROPHIL; NONHUMAN; PARTICLE SIZE; PNEUMONIA; RABBIT; SUSTAINED DRUG RELEASE;

EID: 38349006363     PISSN: 0250474X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Ventresca GP, Mackie AE, Moss JA, McDowell JE, Bye A. Absorption of oral fluticasone propionate in healthy subjects. Am J Respir Med 1994;149:A214.
2. Davies NM, Feddah MR. A novel method for assessing dissolution of aerosol inhaler products. Int J Pharm 2003;255:175-87.
3. Li JT, Caldwell KD. Plasma protein interactions with pluronic treated colloids. Colloids Surfaces B Biointerfaces 1996;7:9-22.
4. Jones BG, Dickinson PA, Gumbleton M, Kellaway IW. The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages. Int J Pharm 2002;236:65-79.